Berenberg reiterates 'buy' rating on Smith and Nephew
7th Oct 2019 10:42
(Sharecast News) - Analysts at Berenberg retained their 'buy' rating on medical equipment manufacturer Smith & Nephew on Monday but slightly lowered their price target on the group from 2,265p to 2,250p.
Read moreWednesday broker round-up
26th Jun 2019 11:25
(Sharecast News) - Ted Baker: RBC Capital Markets downgrades to sector performer with a target price of 900p.
Read moreSmith & Nephew to buy Swiss firm Atracsys
11th Jun 2019 07:27
(Sharecast News) - Smith & Nephew on Tuesday said it was buying Switzerland's Atracsys, a provider of optical tracking technology used in computer-assisted surgery, for an undisclosed sum.
Read moreSmith & Nephew's acquisition of Brainlab completed
3rd Jun 2019 07:19
(Sharecast News) - Smith & Nephew on Monday completed its acquisition of orthopaedic joint reconstruction outfit Brainlab, whose digital workflow technology is used by surgeons in more than 500 hospitals worldwide.
Read moreSmith & Nephew shares rise as board updates revenue guidance
2nd May 2019 07:30
(Sharecast News) - Smith & Nephew reported improved organic revenue growth across its business in its first quarter on Thursday, with revenue in the period rising 4.4% on an underlying basis to $1.2bn.
Read moreMonday broker round-up
29th Apr 2019 13:25
(Sharecast News) - HomeServe: HSBC downgrades to reduce with a target price of 1,000p.
Read moreSmith & Nephew to acquire pressure injury monitor maker Leaf
1st Apr 2019 09:33
(Sharecast News) - Medical technology company Smith & Nephew has agreed to acquire Leaf Healthcare - the developer of the Leaf Patient Monitoring System for pressure injury prevention and patient mobility monitoring - it announced on Monday.
Read moreSmith & Nephew to buy US biotech Osiris Therapeutics for $19 a share
12th Mar 2019 13:06
(Sharecast News) - Medical devices maker Smith & Nephew has agreed to buy US biotechnology company Osiris Therapeutics for $19 per share, which is an enterprise value of around $660m.
Read moreSmith & Nephew drops on NuVasive deal report
11th Feb 2019 09:19
(Sharecast News) - Shares in Smith & Nephew fell on Monday following a report that the maker of hip and knee replacement products is in discussions to buy US medical equipment company NuVasive for more than $3bn.
Read moreThursday preview: BoE in focus
6th Feb 2019 12:11
(Sharecast News) - All eyes will be on the Bank of England today and not just on these shores, given how a 'no-deal' Brexit outcome, and its fall-out, might come just as global growth is at its lowest ebb, in early 2019.
Read moreThursday broker round-up
31st Jan 2019 12:42
(Sharecast News) - Ferrexpo: Deutsche Bank upgrades to buy with a target price of 270p.
Read moreSmith and Nephew acquires US orthopaedics outfit
18th Dec 2018 17:10
(Sharecast News) - Medical technology outfit Smith and Nephew has agreed to acquire Ceterix Orthopaedics in a deal valued as much as $105m.
Read moreMonday broker round-up
10th Dec 2018 13:19
(Sharecast News) - RSA: Jefferies upgrades to buy with a target price of 606p.
Read moreFriday broker round-up
2nd Nov 2018 12:26
(Sharecast News) - Moneysupermarket.com: Liberum upgrades to buy with a target price of 500p.
Read moreBerenberg ups target price on 'sensible' Smith and Nephew
2nd Nov 2018 11:57
(Sharecast News) - Analysts at Berenberg increased their target price on medical equipment manufacturer Smith and Nephew on Friday, but noted that the improved earnings growth reported by the FTSE 100 resident in its third-quarter results appeared to already be priced in.
Read more